Public Law 114-146. Adding Zika Virus to the FDA Priority Review Voucher Program Act
158 words·~1 min read·
/plaw/114/public/146A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
An Act To expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.Apr. 19, 2016[[S. 2512](/us/bill/114/s/2512)] * Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,* Adding Zika Virus to the FDA Priority Review Voucher Program Act. ## SECTION 1 SHORT TITLE [21 USC 301 note](/us/usc/t21/s301). This Act may be cited as the “Adding Zika Virus to the FDA Priority Review Voucher Program Act”. ## SEC. 2 EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS DISEASE Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act ([21 U.S.C. 360n(a)(3)](/us/usc/t21/s360n/a/3)) is amended— ####
(1)by redesignating subparagraph
(R)as subparagraph (S); ####
(2)in subparagraph (Q), by striking “Filoviruses” and inserting “Filovirus Diseases”; and ####
(3)by inserting after subparagraph
(Q)the following: > > ##### “(R) > > Zika Virus Disease.” > . Approved April 19, 2016.
Connections6 cite this · traces to 2
Cited by 6 sections · top 4
Traces to 2 documents
Citation graph
cites case law
Public Law 114-146
Adding Zika Virus to the FDA Priority Review Voucher Program Act
U.S.C.×4
Stat.×2
Cites 2Cited by 6 across 2 sources